Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva's flagship drug Austedo scores new approval at the FDA
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Teva News - Latest teva News, Information & Updates - Health News -ET HealthWorld
Teva shares surge after announcing global opioid settlement
Teva CEO Schultz likely won't renew employment contract: reports
San Francisco reaches $58m opioid settlement with Teva, Allergan | Drugs News | Al Jazeera
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
teva News and latest stories | The Jerusalem Post
Teva Pharmaceuticals USA - News, Articles etc. - European Pharmaceutical Review
Teva News - Latest teva News, Information & Updates - Health News -ET HealthWorld
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
